Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tecsys Inc T.TCS

Alternate Symbol(s):  TCYSF

Tecsys Inc. is a Canada-based company, which is a global provider of advanced supply chain solutions. The Company’s principal business activity is the development, marketing and sale of enterprise-wide supply chain management software for distribution, warehousing, transportation logistics, point-of-use and order management. It also provides related consulting, education and support services. It operates through the development and marketing of enterprise-wide distribution software and related services segment. Its supply chain solutions include Elite Enterprise, Elite Healthcare, Omni Retail and Streamline. The Tecsys Itopia platform is the technology infrastructure on which its Elite Enterprise suite of supply chain applications is built. It offers a range of services including implementation, support services, system enhancement, cloud services and advisory services. Its cloud solutions serve a diverse range of industries, including healthcare, distribution and converging commerce.


TSX:TCS - Post by User

Comment by Possibleidiot01on Sep 06, 2024 9:58pm
51 Views
Post# 36212846

RE:what supports share price

RE:what supports share priceI'll try .
Market cap is $604.3 million.
  • Total revenue increased 12% to $171.2 million compared to $152.4 million in fiscal 2023.
Expected revenue growth of 7-9% gives $186.6 million.

For simplicity's sake , lets call it 3 times sales which isn't terribly overpriced , maybe even fairly priced.

They do have  very desirable hospital supply chain business in which they are the market leader for which there would be many purchasers IMO.

The bad is they aren't a sole focus company -having bought companies pre covid which didn't hurt them .

Their margins are low which i can't figure out .



<< Previous
Bullboard Posts
Next >>